These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34744073)

  • 1. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker.
    Cui M; Qu F; Wang L; Liu X; Yu J; Tang Z; Cheng D
    Cancer Biomark; 2022; 33(3):389-400. PubMed ID: 34744073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
    Sun GF; Ding H
    Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

  • 4. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Pan J; Huang Z; Xu Y
    Front Oncol; 2021; 11():657466. PubMed ID: 34195072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization.
    Zhao Z; Zhou Y; Lv P; Zhou T; Liu H; Xie Y; Wu Z; Wang X; Zhao H; Zheng J; Jiang X
    Cancer Lett; 2024 Aug; 597():217059. PubMed ID: 38876383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma.
    Zhang XW; Wu LY; Liu HR; Huang Y; Qi Q; Zhong R; Zhu L; Gao CF; Zhou L; Yu J; Wu HG
    Oncol Lett; 2022 Dec; 24(6):439. PubMed ID: 36420066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma.
    Nie F; Jiang J; Ning J
    Medicine (Baltimore); 2024 Jun; 103(25):e38623. PubMed ID: 38905403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
    Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
    BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
    Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
    BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
    Pan Q; Yi C; Zhang Y
    Front Oncol; 2022; 12():884377. PubMed ID: 35686101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
    Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
    Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma.
    Liu Y; Zheng S; Wang T; Fang Z; Kong J; Liu J
    Front Cell Dev Biol; 2022; 10():842220. PubMed ID: 35252205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.